The Laboratory  may be required by WADA  to analyze additional EQAS  samples and/or to review the relevant analytical results and to re-analyze any relevant and available Samples  previously reported as Adverse Analytical Findings  25 during the preceding twelve (12) months  (or during a period    25 The Laboratory  may not re -analyze Sample (s) previously reported as Adverse Analytical Findings  if the responsible Anti-Doping Organization  has charged the Athlete  with a Code  Article  2.1 anti -doping rule violation resulting from the analysis of the Sample , without the consent of the Athlete  or approval from a hearing body.